* Biomerica Inc BMRA.OQ BMRA.O is expected to show a rise in
quarterly revenue when it reports results on January 13
(estimated).
* The Irvine California-based company is expected to report a
31.1% increase in revenue to $1.8 million from $1.37 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Biomerica Inc is for a
loss of 8 cents per share. For the same quarter last year, the
company reported a loss of 13 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
This summary was machine generated January 11 at 11:01 GMT. All
figures in US dollars unless otherwise stated